Ajay Munshi

Ajay Munshi has a diverse and extensive work experience spanning over several pharmaceutical and consulting companies. Ajay is currently serving as the VP of Corporate Development at Synlogic since 2022. Before that, they held the position of the Head of Corporate Development at Verastem Oncology from 2019 to 2022. In this role, they were responsible for business development, alliance management, and investor relations. Ajay also worked at Takeda (formerly Shire) as the Alliance Management Lead, Corporate Development from 2017 to 2019, where they managed various external partnerships and collaborations.

Prior to Takeda, Ajay had a significant tenure at Shire Pharmaceuticals from 2013 to 2017. Ajay served as the Head of Portfolio Management, Business Planning, and Corporate Planning & Program Management. Ajay was responsible for developing prioritization processes for investments and planning strategic initiatives. Ajay also worked as the Product Strategy Lead for Vyvanse & Intuniv, where they led the strategy and execution of programs for new indications.

Before joining Shire, Ajay worked at Pfizer as the Strategy Team Lead for the Worldwide Commercial Development, Oncology Business Unit from 2010 to 2012. Ajay led business unit strategy and commercial development initiatives for marketed and pipeline products.

Ajay's earlier experience includes roles at Daiichi Sankyo as the Senior Director of Oncology TA from 2005 to 2010, at Sanofi-Aventis as the Director of Strategic Portfolio Management from 2004 to 2005, at Bogart Delafield Ferrier Consulting as the Vice President from 1999 to 2004, and at Deloitte & Touche as the Manager of Pharmaceutical & Medical Device Practice from 1995 to 1999.

Overall, Ajay Munshi has a proven track record in corporate development, alliance management, strategic planning, and portfolio management within the pharmaceutical industry.

Ajay Munshi has a Bachelor of Science degree in Mechanical Engineering from The Johns Hopkins University. Ajay also holds an MBA degree with a specialization in Finance and International Business from Columbia Business School. Unfortunately, the exact years of their education were not provided.